Aspire Biopharma Holdings, INC. (ASBPW) — 8-K Filings

8-K Filings (24)

• Aspire Biopharma Holdings Files 8-K on Shareholder Vote — Nov 5, 2025 Risk: low
  Aspire Biopharma Holdings, Inc. filed an 8-K on November 5, 2025, reporting on a submission of matters to a vote of security holders that occurred on November 4
• Aspire Biopharma Faces Delisting Notice — Oct 17, 2025 Risk: high
  Aspire Biopharma Holdings, Inc. filed an 8-K on October 17, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing als
• Aspire Biopharma Files 8-K: Equity Sales & Accountant Change — Sep 26, 2025 Risk: medium
  Aspire Biopharma Holdings, Inc. filed an 8-K on September 26, 2025, reporting on unregistered sales of equity securities and changes in its certifying accountan
• Aspire Biopharma Files 8-K for Material Agreement — Aug 22, 2025 Risk: medium
  Aspire Biopharma Holdings, Inc. filed an 8-K on August 22, 2025, reporting a material definitive agreement entered into on August 19, 2025. The filing also incl
• Aspire Biopharma Announces Board and Compensation Changes — Jul 30, 2025 Risk: medium
  Aspire Biopharma Holdings, Inc. announced on July 24, 2025, a change in its board of directors and executive compensation arrangements. The filing details the d
• Aspire Biopharma Files 8-K, Formerly PowerUp Acquisition Corp. — Jun 18, 2025 Risk: low
  Aspire Biopharma Holdings, Inc. filed an 8-K on June 18, 2025, reporting on events that occurred on June 17, 2025. The filing primarily concerns "Other Events"
• Aspire Biopharma Files 8-K: Director Changes & Officer Appointments — Jun 10, 2025 Risk: medium
  Aspire Biopharma Holdings, Inc. filed an 8-K on June 10, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and
• Aspire Biopharma Enters Material Definitive Agreement — Apr 30, 2025 Risk: medium
  Aspire Biopharma Holdings, Inc. entered into a material definitive agreement on April 24, 2025. The filing also includes financial statements and exhibits relat
• Aspire Biopharma Faces Delisting Notice — Apr 18, 2025 Risk: high
  Aspire Biopharma Holdings, Inc. filed an 8-K on April 18, 2025, to report its notice of delisting or failure to satisfy a continued listing rule. The company wa
• Aspire Biopharma Holdings, Inc. Files 8-K with Multiple Material Events — Feb 21, 2025 Risk: medium
  Aspire Biopharma Holdings, Inc. (formerly PowerUp Acquisition Corp.) filed an 8-K on February 21, 2025, detailing several material events. These include enterin
• Aspire Biopharma Announces Material Agreement & Equity Sales — Feb 20, 2025 Risk: medium
  Aspire Biopharma Holdings, Inc. announced on February 13, 2025, the entry into a material definitive agreement. The company also reported the creation of a dire
• PowerUp Acquisition Corp. Files 8-K on Shareholder Vote and Financials — Feb 10, 2025 Risk: low
  PowerUp Acquisition Corp. filed an 8-K on February 10, 2025, reporting events as of February 4, 2025. The filing primarily concerns the submission of matters to
• PowerUp Acquisition Corp. Files 8-K for Material Agreement — Dec 26, 2024 Risk: medium
  PowerUp Acquisition Corp. filed an 8-K on December 26, 2024, reporting a material definitive agreement entered into on December 18, 2024. The filing also covers
• PowerUp Acquisition Corp. Signs Material Definitive Agreement — Oct 10, 2024 Risk: medium
  PowerUp Acquisition Corp. entered into a material definitive agreement on October 9, 2024. The filing also includes financial statements and exhibits related to
• PowerUp Acquisition Corp. Signs Material Definitive Agreement — Oct 4, 2024 Risk: medium
  PowerUp Acquisition Corp. entered into a material definitive agreement on October 2, 2024. The filing also includes financial statements and exhibits related to
• PowerUp Acquisition Corp. Files 8-K for Definitive Agreement — Sep 6, 2024 Risk: medium
  PowerUp Acquisition Corp. filed an 8-K on September 6, 2024, reporting the entry into a material definitive agreement. The filing also includes financial statem
• PowerUp Acquisition Corp. Files 8-K — Sep 3, 2024 Risk: low
  PowerUp Acquisition Corp. filed an 8-K on September 3, 2024, reporting other events and financial statements. The company, formerly known as PowsedrUp Acquisiti
• PowerUp Acquisition Corp. Signs Material Definitive Agreement — Aug 30, 2024 Risk: medium
  PowerUp Acquisition Corp. entered into a material definitive agreement on August 26, 2024. The filing does not specify the other party or the nature of the agre
• PowerUp Acquisition Corp. Terminates Material Agreement — Jul 23, 2024 Risk: medium
  PowerUp Acquisition Corp. filed an 8-K on July 23, 2024, reporting the termination of a material definitive agreement as of July 19, 2024. The filing also inclu
• PowerUp Acquisition Corp. Signs Material Definitive Agreement — Jun 7, 2024 Risk: low
  PowerUp Acquisition Corp. entered into a material definitive agreement on June 6, 2024. The company, formerly known as PowsedrUp Acquisition Corp., is incorpora
• PowerUp Acquisition Corp. Files 8-K on Shareholder Vote & Bylaws — May 28, 2024 Risk: low
  PowerUp Acquisition Corp. filed an 8-K on May 28, 2024, reporting on matters submitted to a vote of security holders and amendments to its articles of incorpora
• PowerUp Acquisition Corp. Files 8-K for Material Agreement — May 22, 2024 Risk: medium
  PowerUp Acquisition Corp. filed an 8-K on May 22, 2024, to report the entry into a material definitive agreement. The filing also includes financial statements
• PowerUp Acquisition Corp. Files 8-K — May 20, 2024 Risk: medium
  PowerUp Acquisition Corp. filed an 8-K on May 20, 2024, reporting the entry into a material definitive agreement. The filing also includes other events and fina
• PowerUp Acquisition Corp. Files 8-K — May 16, 2024 Risk: low
  PowerUp Acquisition Corp. filed an 8-K on May 16, 2024, reporting other events and financial statements. The company, incorporated in the Cayman Islands, is inv

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX